Stock Analysis on Net
Stock Analysis on Net

Eli Lilly & Co. (NYSE:LLY)

$24.99

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Paying user area

Try for free

Eli Lilly & Co. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Eli Lilly & Co., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Short-term borrowings and current maturities of long-term debt
Accounts payable
Employee compensation
Sales rebates and discounts
Other current liabilities
Current liabilities
Long-term debt, excluding current maturities
Long-term income taxes payable
Other noncurrent liabilities
Noncurrent liabilities
Total liabilities
Common stock, no par value
Additional paid-in capital
Retained earnings
Employee benefit trust
Accumulated other comprehensive loss
Other equity
Total Eli Lilly and Company shareholders’ equity
Noncontrolling interests
Total equity
Total liabilities and equity

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

The composition of liabilities and stockholders’ equity at the company exhibits several notable shifts between 2021 and 2025. Overall, a dynamic pattern emerges, with fluctuations in both the liability and equity structures. A significant trend is the decrease in total liabilities as a percentage of total liabilities and equity from 81.24% in 2021 to 76.41% in 2025, accompanied by a corresponding increase in total equity.

Current Liabilities
Current liabilities initially increased from 30.84% in 2021 to a peak of 42.64% in 2023, before declining to 31.32% in 2025. This fluctuation is largely driven by changes in sales rebates and discounts, which rose from 14.03% to 18.26% and then decreased to 15.45%. Short-term borrowings also experienced a substantial increase in 2023 (10.79%) before falling significantly to 1.45% in 2025. Accounts payable remained relatively stable, increasing gradually from 3.42% to 4.78% over the period.
Noncurrent Liabilities
Noncurrent liabilities decreased from 50.40% in 2021 to 40.39% in 2023, then increased to 45.09% in 2025. Long-term debt, excluding current maturities, demonstrates a similar pattern, fluctuating from 31.44% to 28.62% and then rising to 36.33%. Long-term income taxes payable consistently decreased from 8.03% to 5.22% during the period. Other noncurrent liabilities also showed a declining trend.
Stockholders’ Equity
Total stockholders’ equity increased from 18.76% in 2021 to 23.59% in 2025. Retained earnings contributed significantly to this increase, rising from 18.36% to 21.76%. However, common stock and additional paid-in capital both decreased over the period, from 1.22% and 14.00% respectively, to 0.52% and 6.53%. The employee benefit trust and accumulated other comprehensive loss both decreased in absolute percentage terms, becoming less negative over time. Noncontrolling interests decreased from 0.36% to 0.10%.

The shifts in the liability structure suggest potential changes in the company’s financing strategies and operational practices. The increase in equity, particularly through retained earnings, indicates profitability and effective capital management. The decreasing trends in certain equity components, such as common stock and additional paid-in capital, warrant further investigation to understand the underlying reasons. Overall, the company’s financial position appears to be strengthening, with a decreasing reliance on liabilities and a growing equity base.